182 related articles for article (PubMed ID: 38553613)
1. Deubiquitinating enzyme OTUD4 stabilizes RBM47 to induce ATF3 transcription: a novel mechanism underlying the restrained malignant properties of ccRCC cells.
Li Z; Tian Y; Zong H; Wang X; Li D; Keranmu A; Xin S; Ye B; Bai R; Chen W; Yang G; Ye L; Wang S
Apoptosis; 2024 Mar; ():. PubMed ID: 38553613
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of RNA binding protein 47 predicts low survival in patients and promotes the development of renal cell malignancies through RNA stability modification.
Wang C; Li W; Meng X; Yuan H; Yu T; Yang W; Ni D; Liu L; Xiao W
Mol Biomed; 2023 Nov; 4(1):41. PubMed ID: 37962768
[TBL] [Abstract][Full Text] [Related]
3. Activating transcription factor 3 is a new biomarker correlation with renal clear cell carcinoma progression.
Yang Z; Hou Y; Li J; Xu D; Yang Z; Wang X
Int J Immunopathol Pharmacol; 2024; 38():3946320241227320. PubMed ID: 38248871
[No Abstract] [Full Text] [Related]
4. Ubiquitin-specific peptidase 53 inhibits the occurrence and development of clear cell renal cell carcinoma through NF-κB pathway inactivation.
Gui D; Dong Z; Peng W; Jiang W; Huang G; Liu G; Ye Z; Wang Y; Xu Z; Fu J; Luo S; Zhao Y
Cancer Med; 2021 Jun; 10(11):3674-3688. PubMed ID: 33973730
[TBL] [Abstract][Full Text] [Related]
5. ATF3 Suppresses Growth and Metastasis of Clear Cell Renal Cell Carcinoma by Deactivating EGFR/AKT/GSK3β/β-Catenin Signaling Pathway.
Gao S; Gao L; Wang S; Shi X; Yue C; Wei S; Zuo L; Zhang L; Qin X
Front Cell Dev Biol; 2021; 9():618987. PubMed ID: 33816467
[TBL] [Abstract][Full Text] [Related]
6. OTUD4: A Potential Prognosis Biomarker for Multiple Human Cancers.
Zhao X; Su X; Cao L; Xie T; Chen Q; Li J; Xu R; Jiang C
Cancer Manag Res; 2020; 12():1503-1512. PubMed ID: 32184655
[TBL] [Abstract][Full Text] [Related]
7. OTUD4 promotes the progression of glioblastoma by deubiquitinating CDK1 and activating MAPK signaling pathway.
Ci M; Zhao G; Li C; Liu R; Hu X; Pan J; Shen Y; Zhang G; Li Y; Zhang L; Liang P; Cui H
Cell Death Dis; 2024 Mar; 15(3):179. PubMed ID: 38429268
[TBL] [Abstract][Full Text] [Related]
8. USP15, activated by TFAP4 transcriptionally, stabilizes SHC1 via deubiquitination and deteriorates renal cell carcinoma.
Shi Y; Zhang J; Li J; He J; Wu S; Yu M; Yang D; Ju L
Cancer Sci; 2024 Jun; ():. PubMed ID: 38847328
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitinating enzyme OTUD4 regulates metastasis in triple-negative breast cancer by stabilizing Snail1.
Ma X; Wan R; Wen Y; Liu T; Song Y; Zhu Y
Exp Cell Res; 2024 Jan; 434(1):113864. PubMed ID: 38040050
[TBL] [Abstract][Full Text] [Related]
10. Long Non-Coding RNA LUCAT1 Promotes Proliferation and Invasion in Clear Cell Renal Cell Carcinoma Through AKT/GSK-3β Signaling Pathway.
Zheng Z; Zhao F; Zhu D; Han J; Chen H; Cai Y; Chen Z; Xie W
Cell Physiol Biochem; 2018; 48(3):891-904. PubMed ID: 30032137
[TBL] [Abstract][Full Text] [Related]
11. OTUD4-mediated GSDME deubiquitination enhances radiosensitivity in nasopharyngeal carcinoma by inducing pyroptosis.
Di M; Miao J; Pan Q; Wu Z; Chen B; Wang M; Zhao J; Huang H; Bai J; Wang Q; Tang Y; Li Y; He J; Xiang T; Weng D; Wang L; Xia J; Zhao C
J Exp Clin Cancer Res; 2022 Nov; 41(1):328. PubMed ID: 36411454
[TBL] [Abstract][Full Text] [Related]
12. Long noncoding RNA lnc-DILC stabilizes PTEN and suppresses clear cell renal cell carcinoma progression.
Zhang H; Wei P; Lv W; Han X; Yang J; Qin S
Cell Biosci; 2019; 9():81. PubMed ID: 31592114
[TBL] [Abstract][Full Text] [Related]
13. NRF2 regulates EGF stability through OTUD4 in lung adenocarcinoma.
Hu S; Yuan Y; Yan R; Xie H; Cai R; Xu J
Biochem Biophys Res Commun; 2024 May; 708():149798. PubMed ID: 38518721
[TBL] [Abstract][Full Text] [Related]
14. Induction of OTUD4 by viral infection promotes antiviral responses through deubiquitinating and stabilizing MAVS.
Liuyu T; Yu K; Ye L; Zhang Z; Zhang M; Ren Y; Cai Z; Zhu Q; Lin D; Zhong B
Cell Res; 2019 Jan; 29(1):67-79. PubMed ID: 30410068
[TBL] [Abstract][Full Text] [Related]
15. Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.
Shi Z; Zheng J; Liang Q; Liu Y; Yang Y; Wang R; Wang M; Zhang Q; Xuan Z; Sun H; Wang K; Shao C
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230613
[TBL] [Abstract][Full Text] [Related]
16. CSE reduces OTUD4 triggering lung epithelial cell apoptosis via PAI-1 degradation.
Luo L; Li T; Zeng Z; Li H; He X; Chen Y
Cell Death Dis; 2023 Sep; 14(9):614. PubMed ID: 37726265
[TBL] [Abstract][Full Text] [Related]
17. MIOX inhibits autophagy to regulate the ROS -driven inhibition of STAT3/c-Myc-mediated epithelial-mesenchymal transition in clear cell renal cell carcinoma.
Meng L; Gao J; Mo W; Wang B; Shen H; Cao W; Ding M; Diao W; Chen W; Zhang Q; Shu J; Dai H; Guo H
Redox Biol; 2023 Dec; 68():102956. PubMed ID: 37977044
[TBL] [Abstract][Full Text] [Related]
18. RBM47 inhibits hepatocellular carcinoma progression by targeting UPF1 as a DNA/RNA regulator.
Guo T; You K; Chen X; Sun Y; Wu Y; Wu P; Jiang Y
Cell Death Discov; 2022 Jul; 8(1):320. PubMed ID: 35831298
[TBL] [Abstract][Full Text] [Related]
19. SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma
Wu M; Guo Q; Liu X; Wu L
Exp Ther Med; 2022 May; 23(5):317. PubMed ID: 35350667
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of lncRNA APCDD1L-AS1 due to DNA hypermethylation and loss of VHL protein expression promotes the progression of clear cell renal cell carcinoma.
Yang W; Zhou J; Zhang Z; Zhang K; Xu Y; Li L; Cai L; Gong Y; Gong K
Int J Biol Sci; 2022; 18(6):2583-2596. PubMed ID: 35414787
[No Abstract] [Full Text] [Related]
[Next] [New Search]